CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 129 filers reported holding CARA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $174,506 | -55.4% | 35,541 | -2.5% | 0.00% | -33.3% |
Q4 2022 | $391,473 | -76.9% | 36,450 | -60.7% | 0.00% | -76.9% |
Q3 2019 | $1,697,000 | -5.1% | 92,860 | +11.6% | 0.01% | 0.0% |
Q2 2019 | $1,789,000 | -4.3% | 83,200 | -12.7% | 0.01% | 0.0% |
Q1 2019 | $1,869,000 | +57.7% | 95,279 | +4.5% | 0.01% | +44.4% |
Q4 2018 | $1,185,000 | +523.7% | 91,164 | +197.7% | 0.01% | +350.0% |
Q1 2016 | $190,000 | -68.6% | 30,625 | -14.6% | 0.00% | -66.7% |
Q4 2015 | $605,000 | -89.8% | 35,873 | -13.8% | 0.01% | 0.0% |
Q3 2015 | $5,947,000 | +2062.5% | 41,616 | +84.0% | 0.01% | +200.0% |
Q2 2015 | $275,000 | +141.2% | 22,623 | +100.2% | 0.00% | +100.0% |
Q1 2015 | $114,000 | – | 11,298 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chescapmanager LLC | 1,655,576 | $4,685,280 | 0.73% |
Bain Capital Life Sciences Investors, LLC | 934,898 | $2,645,761 | 0.27% |
FNY Investment Advisers, LLC | 35,000 | $99 | 0.12% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,764,201 | $4,992,689 | 0.11% |
Ergoteles LLC | 358,275 | $1,013,918 | 0.05% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $239,220 | 0.04% |
PDT Partners, LLC | 85,088 | $240,799 | 0.03% |
PINNACLE ASSOCIATES LTD | 672,440 | $1,903,005 | 0.03% |
Alpine Global Management, LLC | 34,014 | $96,260 | 0.03% |
XTX Topco Ltd | 52,025 | $147,231 | 0.03% |